These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6437818)
1. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide. McDevitt DG Eur Heart J; 1984 Sep; 5 Suppl B():63-6. PubMed ID: 6437818 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
3. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide. Pottage A Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279 [TBL] [Abstract][Full Text] [Related]
4. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide. Camm AJ Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820 [No Abstract] [Full Text] [Related]
6. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias. Orning OM Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821 [No Abstract] [Full Text] [Related]
8. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related]
9. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. Woosley RL; Echt DS; Roden DM Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860 [TBL] [Abstract][Full Text] [Related]
10. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone. Kreeger RW; Hammill SC Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116 [TBL] [Abstract][Full Text] [Related]
11. Metabolites of cardiac antiarrhythmic drugs: their clinical role. Kates RE Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496 [TBL] [Abstract][Full Text] [Related]
12. Therapy with investigational antiarrhythmic drugs. Mead RH; Harrison DC Med Clin North Am; 1984 Sep; 68(5):1321-37. PubMed ID: 6436596 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of antiarrhythmic agents. Kelliher GJ; Kowey P; Engel T; Wetstein L Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883 [No Abstract] [Full Text] [Related]
14. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Hellestrand KJ Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822 [No Abstract] [Full Text] [Related]
15. Clinical pharmacology of old and new antiarrhythmic drugs. Siddoway LA; Roden DM; Woosley RL Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805 [TBL] [Abstract][Full Text] [Related]
17. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide]. Halawa B Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685 [TBL] [Abstract][Full Text] [Related]
18. Reliability of antiarrhythmic drug plasma concentration monitoring. Follath F; Ganzinger U; Schuetz E Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of antiarrhythmic drugs. Block PJ; Winkle RA Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278 [TBL] [Abstract][Full Text] [Related]
20. Selection of an antiarrhythmic drug for a sudden-death-prevention trial. Woosley RL; Roden DM; Duff HJ; Oates JA Am Heart J; 1982 Apr; 103(4 Pt 2):737-45. PubMed ID: 6175198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]